Aquaculture Vaccines Market Report: Size, Share, Innovation Trends, and Forecast 2031 | 2025 - Key Developments and Competitive Landscape

Aquaculture Vaccines Market Size and Forecast

Aquaculture Vaccines Market is valued at a significant CAGR during the forecast period (2024-2031). As per DataM Intelligence Database.

DataM Intelligence has published a new research report on "Aquaculture Vaccines Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Exclusive Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/aquaculture-vaccines-market?rk

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Recent Developments:

✅ October 2025: A leading aquaculture health company launched a next-generation DNA-based vaccine for salmonid diseases, offering improved immune response and longer protection cycles. The vaccine supports reduced antibiotic use, aligning with global sustainability and responsible aquaculture initiatives.

✅ August 2025: Researchers in Norway successfully commercialized an oral vaccine for sea lice control, enabling stress-free mass immunization in farmed salmon. This innovation significantly lowers handling-related mortality and improves farm-level productivity.

✅ June 2025: An Asia-based biotech firm introduced a multivalent inactivated vaccine for shrimp, targeting early mortality syndrome (EMS) and white spot syndrome virus (WSSV). The product is designed to enhance survival rates in high-density shrimp farming systems.

✅ April 2025: Advances in recombinant vaccine technology led to the development of highly specific vaccines against Vibrio and Aeromonas species, improving disease control in tilapia and carp aquaculture across emerging markets.

Mergers & Acquisitions:

✅ November 2025: A global animal health company acquired a specialized aquatic vaccine R&D startup, strengthening its portfolio of injectable and immersion vaccines for finfish species.

✅ September 2025: A multinational pharmaceutical group completed the acquisition of a fish vaccine manufacturing facility in Southeast Asia, expanding production capacity to meet rising demand from shrimp and warm-water fish farming.

✅ July 2025: A European veterinary biologics company acquired a genomics-based aquatic health firm, enabling the integration of pathogen surveillance and precision vaccine development for aquaculture operations.

✅ May 2025: A major aquafeed producer acquired a vaccine delivery technology provider, enhancing oral and feed-based vaccine administration platforms to improve adoption among small and medium-scale fish farmers.

Key Players:

Merck & Co., Inc., Tecnovax, Hipra, Zoetis LLC, Phibro Animal Health Corporation, Elanco, KBNP, INC., Kyoto Biken Laboratories, Inc., Veterquimica S.A., Virbac S.A.

Growth Forecast Projected:

The Global Aquaculture Vaccines Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Aquaculture Vaccines Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=aquaculture-vaccines-market?rk

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Key Segments:

By Type
The market is segmented into Inactivated Vaccines 40%, Attenuated Live Vaccines 25%, Recombinant Vaccines 20%, Subunit Vaccines 10%, and DNA Vaccines 5%, with inactivated vaccines dominating due to their high safety profile, stability, and wide regulatory acceptance in aquaculture. Attenuated live vaccines are widely used for strong and long-lasting immune response. Recombinant vaccines are gaining traction with advancements in biotechnology and targeted disease control. Subunit and DNA vaccines represent emerging segments with growing R&D focus.

By Route of Administration
By route of administration, the market includes Injected 45%, Immersion 30%, Oral 20%, and Others 5%, with injected vaccines leading due to precise dosing and high efficacy in high-value fish species. Immersion vaccination is widely used for mass immunization of juvenile fish. Oral vaccines are gaining adoption due to ease of administration and reduced stress on fish. Technological improvements support broader adoption across routes.

By Application
By application, the market comprises Bacterial Infection 55%, Viral Infection 30%, Parasitic Infection 10%, and Others 5%, with bacterial infection vaccines dominating due to high prevalence of bacterial diseases in aquaculture operations. Viral infection vaccines show strong growth driven by increasing disease outbreaks and mortality rates. Parasitic infection vaccines are emerging with expanding research efforts.

By Species Type
Based on species type, the market is segmented into Salmon 35%, Tilapia 25%, Trout 15%, Seabass 10%, Seabream 8%, and Others 7%, with salmon dominating due to high commercial value and intensive farming practices. Tilapia holds a significant share driven by large-scale production in Asia and Latin America. Trout, seabass, and seabream support steady demand across regional aquaculture industries.

By End-User
By end-user, the market is segmented into Veterinary Clinics 45%, Veterinary Hospitals 35%, and Others 20%, with veterinary clinics dominating due to their widespread presence and routine vaccination services in aquaculture. Veterinary hospitals are preferred for large-scale and specialized vaccination programs. Other end-users include aquaculture farms and research facilities supporting disease prevention initiatives.

Regional Analysis
Asia Pacific - 40% Share
Asia Pacific leads with 40% share due to large-scale aquaculture production, high fish consumption, and widespread farming of tilapia and carp in China, India, Vietnam, and Indonesia. Bacterial vaccines and immersion methods dominate. Strong government support for aquaculture health drives market growth.

Europe - 25% Share
Europe accounts for 25% share, driven by advanced aquaculture practices and high salmon farming activity in Norway, Scotland, and Iceland. Injected and recombinant vaccines dominate usage. Strict fish health regulations support adoption.

North America - 15% Share
North America holds 15% share, supported by salmon and trout farming in the U.S. and Canada. High adoption of injected vaccines and strong veterinary infrastructure drive demand. Focus on sustainable aquaculture boosts market growth.

Latin America - 12% Share
Latin America captures 12% share, driven by expanding salmon farming in Chile and tilapia production in Brazil. Bacterial and viral vaccines dominate. Growing export-oriented aquaculture supports regional adoption.

Middle East & Africa - 8% Share
The Middle East & Africa region holds 8% share, supported by growing aquaculture investments, fish farming expansion, and disease management initiatives in Egypt, Saudi Arabia, and South Africa. Oral and immersion vaccines show increasing adoption.

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/aquaculture-vaccines-market?rk

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

FAQ

Q: How rapidly will the Market expand?

A: The Aquaculture Vaccines market is projected to grow at a CAGR of 8% between 2024 and 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?rk

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.